INSM
Insmed Incorporated
Stock
$111.12+2.53 (+2.33%)Close Oct 2, 2026
- Research and development, 2025
- $771M
- YoY, 2025
- +28.9%
- 5-year CAGR
- +33.6%
- 10-year CAGR
- +26.4%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $771M | +28.9% |
| 2024 | $598M | +4.8% |
| 2023 | $571M | +43.6% |
| 2022 | $398M | +45.7% |
| 2021 | $273M | +50.6% |
| 2020 | $181M | +37.5% |
| 2019 | $132M | −9.3% |
| 2018 | $145M | +32.4% |
| 2017 | $110M | −10.6% |
| 2016 | $123M | +65.2% |
| 2015 | $74M | +31.9% |
| 2014 | $56M | +27.1% |
| 2013 | $44M | +48.7% |
| 2012 | $30M | +4.0% |
| 2011 | $29M | +508.7% |
| 2010 | $4.7M | −48.9% |
| 2009 | $9.2M | — |